Exciting new research partnership

The Leukemia & Lymphoma Society of Canada, in partnership with the Canadian Cancer Society (CCS), is pleased to announce the recipient of a 2021 CCS Spark Grant.

The intent of the Novel Technology Application in Cancer Prevention and Early Detection program is to “spark” and accelerate new activity in the development and/or application of truly novel approaches to cancer prevention and early detection.

Donate Today      

 

2021 Spark Grants

Dr. Maja Krajinovic

Dr. Maja Krajinovic

CHU Sainte-Justine Research Centre
Montreal, Quebec MicroDNA signature for prognosis of childhood acute lymphoblastic leukemia Acute lymphoblastic leukemia (ALL) is the most common type of childhood blood cancer, and relapsed and treatment-resistant ALL poses significant challenges in terms of clinical management. Being able to diagnose new and relapsed cases of ALL earlier would allow people to receive ...